[go: up one dir, main page]

PH22801A - 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof and antibacterial agents comprising the same - Google Patents

1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof and antibacterial agents comprising the same

Info

Publication number
PH22801A
PH22801A PH32174A PH32174A PH22801A PH 22801 A PH22801 A PH 22801A PH 32174 A PH32174 A PH 32174A PH 32174 A PH32174 A PH 32174A PH 22801 A PH22801 A PH 22801A
Authority
PH
Philippines
Prior art keywords
dihydro
salts
same
antibacterial agents
oxonaphthyridine derivatives
Prior art date
Application number
PH32174A
Inventor
Hirokazu Narita
Hideyoshi Nagaki
Isao Kitayama
Yoriko Kobayashi
Yasuo Watanabe
Shinzaburo Minami
Isamu Saikawa
Yoshinori Konishi
Jun Nitta
Mikako Shinagawa
Akira Yotsuji
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13845280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH22801(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of PH22801A publication Critical patent/PH22801A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PH32174A 1984-04-26 1985-04-23 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof and antibacterial agents comprising the same PH22801A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59084963A JPS60228479A (en) 1984-04-26 1984-04-26 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof

Publications (1)

Publication Number Publication Date
PH22801A true PH22801A (en) 1988-12-12

Family

ID=13845280

Family Applications (3)

Application Number Title Priority Date Filing Date
PH32174A PH22801A (en) 1984-04-26 1985-04-23 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof and antibacterial agents comprising the same
PH35958A PH25046A (en) 1984-04-26 1987-10-20 A process for producing 1,4-duhydro-4-oxo-naphthyridine and salts thereof
PH35960A PH25228A (en) 1984-04-26 1987-10-20 A process for producing 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof

Family Applications After (2)

Application Number Title Priority Date Filing Date
PH35958A PH25046A (en) 1984-04-26 1987-10-20 A process for producing 1,4-duhydro-4-oxo-naphthyridine and salts thereof
PH35960A PH25228A (en) 1984-04-26 1987-10-20 A process for producing 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof

Country Status (30)

Country Link
JP (1) JPS60228479A (en)
KR (1) KR870001693B1 (en)
AR (1) AR241911A1 (en)
AT (2) AT389698B (en)
AU (2) AU565087B2 (en)
BE (1) BE902279A (en)
CH (1) CH673458A5 (en)
CS (1) CS250684B2 (en)
DD (1) DD238795A5 (en)
DE (2) DE3514076A1 (en)
DK (1) DK165877C (en)
EG (1) EG17339A (en)
ES (2) ES8700256A1 (en)
FI (1) FI80453C (en)
FR (2) FR2563521B1 (en)
GB (2) GB2158825B (en)
HU (2) HU197571B (en)
ID (1) ID21142A (en)
IL (1) IL75021A (en)
IT (1) IT1209953B (en)
LU (1) LU85871A1 (en)
NL (2) NL187314C (en)
NO (1) NO162238C (en)
NZ (1) NZ211895A (en)
PH (3) PH22801A (en)
PL (1) PL147392B1 (en)
PT (1) PT80349B (en)
RO (2) RO95509B (en)
SE (2) SE463102B (en)
ZA (1) ZA853102B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6172753A (en) * 1984-09-18 1986-04-14 Dainippon Pharmaceut Co Ltd Pyridyl ketone derivative
AT392789B (en) * 1985-01-23 1991-06-10 Toyama Chemical Co Ltd METHOD FOR PRODUCING 1-SUBSTITUTED ARYL-1,4-DIHYDRO-4-OXONAPHTHYRIDINE DERIVATIVES
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (en) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen ANTIBACTERIAL EFFECT OF CHINOLON CARBON ACID ESTERS
IL79189A (en) * 1985-06-26 1990-07-12 Daiichi Seiyaku Co Quinoline and/or naphthyridine-4-oxo-3-carboxylic acid derivatives,process for their preparation and pharmaceutical compositions comprising them
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
US4859776A (en) * 1988-03-11 1989-08-22 Abbott Laboratories (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation
JP2844079B2 (en) * 1988-05-23 1999-01-06 塩野義製薬株式会社 Pyridonecarboxylic acid antibacterial agent
DE3934082A1 (en) * 1989-10-12 1991-04-18 Bayer Ag CHINOLON CARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AN ANTIVIRAL AGENT
WO1992012155A1 (en) * 1991-01-14 1992-07-23 Hanmi Pharmaceutical Co., Ltd. Novel quinolone compounds and processes for preparation thereof
FR2692577B1 (en) * 1992-05-26 1996-02-02 Bouchara Sa NOVEL FLUORINATED QUINOLONES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
KR940014395A (en) * 1992-12-09 1994-07-18 강박광 Novel quinolone derivatives and preparation methods thereof
KR0148277B1 (en) * 1993-01-18 1998-11-02 채영복 Novel fluoroquinolone derivatives and process for the preparation thereof
AU4272793A (en) * 1993-04-24 1994-11-21 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
KR950018003A (en) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 Novel quinolone derivatives and methods for their preparation
WO1996012704A1 (en) * 1994-10-20 1996-05-02 Wakunaga Seiyaku Kabushiki Kaisha Novel pyridonecarboxylate derivative or salt thereof and antibacterial containing the same as active ingredient
DE69729565T2 (en) 1996-04-19 2005-06-09 Wakunaga Pharmaceutical Co., Ltd. New pyridonecarboxylic acid derivatives or salts of these derivatives and antibacterial agents containing these active agents
AU5050898A (en) * 1996-10-30 1998-05-22 Bayer Aktiengesellschaft Method or producing naphthyridine compounds and novel intermediate products
DE19713506A1 (en) 1997-04-01 1998-10-08 Bayer Ag Process for the preparation of 2,6-dichloro-5-fluoronicotinonitrile and the chemical compound 3-cyano-2-hydroxy-5-fluoropyrid-6-one monosodium salt and its tautomers
AU3192700A (en) 1999-03-17 2000-10-04 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
DE19926400A1 (en) 1999-06-10 2000-12-14 Bayer Ag Improved process for the preparation of 2,6-dichloro-5-fluoro-nicotinic acid and coarse and particularly pure 2,6-dichloro-5-fluoro-nicotinic acid
AU6868700A (en) 1999-09-02 2001-04-10 Wakunaga Pharmaceutical Co., Ltd Quinolinecarboxylic acid derivative or its salt
AU2001286852A1 (en) * 2000-08-29 2002-03-13 Chiron Corporation Quinoline antibacterial compounds and methods of use thereof
KR100981351B1 (en) * 2003-10-29 2010-09-10 주식회사 엘지생명과학 Method for preparing 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
CN101792443A (en) * 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 Fluoro-carbostyril derivative as well as preparation method and application thereof
JOP20190045A1 (en) 2016-09-14 2019-03-14 Bayer Ag Amide-1-aryl-naphthridine-3-carboxylic acid amide compounds are substituted at position 7 and used.
CN114369092A (en) * 2021-12-20 2022-04-19 赤峰万泽药业股份有限公司 Tosufloxacin tosylate and preparation method thereof
CN116606279A (en) * 2023-03-13 2023-08-18 广东工业大学 A kind of fluoroquinolone compound and its preparation method and application

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
AR223983A1 (en) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co A PROCEDURE FOR PREPARING 6-HALOGEN-4-OXO-7- (1-PIPERAZINYL) -1,8-NAFTIRIDIN-3-CARBOXYLIC ACID DERIVATIVES
DE3033157A1 (en) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-AMINO-1-CYCLOPROPYL-4-OXO-1,4-DIHYDRO-NAPHTHYRIDINE-3-CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THE ANTIBACTERIAL AGENTS CONTAINING THEM
US4382937A (en) * 1981-02-27 1983-05-10 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives and their use as anti-bacterials
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
IL74064A (en) * 1984-01-26 1988-09-30 Abbott Lab 1,7-disubstituted-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and antibacterial compositions containing them
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (en) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen ANTIBACTERIAL EFFECT OF CHINOLON CARBON ACID ESTERS

Also Published As

Publication number Publication date
IL75021A0 (en) 1985-08-30
FI80453B (en) 1990-02-28
ID21142A (en) 1999-04-29
FR2563521A1 (en) 1985-10-31
FI851637L (en) 1985-10-27
DK185685D0 (en) 1985-04-25
SE8502017D0 (en) 1985-04-25
HU197571B (en) 1989-04-28
SE8502017L (en) 1985-10-27
CS250684B2 (en) 1987-05-14
AR241911A1 (en) 1993-01-29
KR870001693B1 (en) 1987-09-24
JPS60228479A (en) 1985-11-13
BE902279A (en) 1985-10-25
RO95509A (en) 1988-09-30
LU85871A1 (en) 1985-12-16
AU612993B2 (en) 1991-07-25
GB2191776B (en) 1990-03-28
FI851637A0 (en) 1985-04-25
SE463102B (en) 1990-10-08
CH673458A5 (en) 1990-03-15
HUT38634A (en) 1986-06-30
JPS6320828B2 (en) 1988-04-30
GB8716897D0 (en) 1987-08-26
EG17339A (en) 1989-06-30
SE501412C2 (en) 1995-02-13
PH25228A (en) 1991-03-27
RO91871B (en) 1987-07-31
FR2563521B1 (en) 1989-02-03
NL8501172A (en) 1985-11-18
FR2614620B1 (en) 1990-03-09
DK165877B (en) 1993-02-01
RO91871A (en) 1987-07-30
AT390258B (en) 1990-04-10
ZA853102B (en) 1986-12-30
ES8706673A1 (en) 1987-07-01
GB2191776A (en) 1987-12-23
SE8804586D0 (en) 1988-12-20
NL187314C (en) 1991-08-16
GB2158825B (en) 1989-01-25
DK165877C (en) 1993-06-21
DE3514076A1 (en) 1985-10-31
PT80349A (en) 1985-05-01
DD238795A5 (en) 1986-09-03
PL253108A1 (en) 1985-12-17
ES8700256A1 (en) 1986-09-16
AT389698B (en) 1990-01-10
SE8804586L (en) 1988-12-20
ATA122485A (en) 1989-06-15
DE3514076C2 (en) 1989-03-30
AU8180487A (en) 1988-03-24
PT80349B (en) 1987-09-30
DE3546658C2 (en) 1992-04-02
FI80453C (en) 1990-06-11
ES542584A0 (en) 1986-09-16
AU4165085A (en) 1985-10-31
FR2614620A1 (en) 1988-11-04
NL9100648A (en) 1991-08-01
NO162238B (en) 1989-08-21
PL147392B1 (en) 1989-05-31
RO95509B (en) 1988-10-01
AU565087B2 (en) 1987-09-03
GB2158825A (en) 1985-11-20
PH25046A (en) 1991-01-28
IT8548002A0 (en) 1985-04-26
ES551538A0 (en) 1987-07-01
HU194226B (en) 1988-01-28
IL75021A (en) 1994-01-25
KR850007596A (en) 1985-12-07
NZ211895A (en) 1988-07-28
NO851643L (en) 1985-10-28
DK185685A (en) 1985-10-27
ATA267888A (en) 1989-09-15
NO162238C (en) 1989-12-06
GB8510297D0 (en) 1985-05-30
IT1209953B (en) 1989-08-30

Similar Documents

Publication Publication Date Title
PH22801A (en) 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof and antibacterial agents comprising the same
EP0423358A4 (en) Postostatin and related compound thereof, or their salts
GB2153821B (en) 3-imidazolylmethyl-1,2,3,9-tetrahydro-4h-carbazol-4-one derivatives
AU568004B2 (en) Antibacterial 1,4 hydro-quinolines and 1,8-napthridines
PH22614A (en) 9-amino-1,2,3,4-tetrahydroacridin-1-alpha and related compounds and their use as medicament
AU566984B2 (en) Antibacterial 1,8-napthyridine and quinoune derivatives and their further fused analogues
PH23474A (en) Antibacterial agents
EP0202580A3 (en) 3,4-dihydrobenzopyran derivatives
DE3666820D1 (en) 5,6-difluoronaphthyridines and 5,6,8-trifluoro-quinolines as antibacterial agents
OA07955A (en) Antibacterial agents.
ZA869591B (en) Substituted 5,6-dialkoxyquinazoline derivatives
GB2173195B (en) N,n'-diaminocarbonylmethyl-n,n'-dicarboxymethyl-1,2-diaminoethane derivatives
GB2161161B (en) Antibacterial 7-oxo-4-thia-1-azabicyclo/o.3 2 0/-hept-2-ene derivatives
EP0183975A3 (en) 5,6,7,8-tetrafluoroanthraquinone derivatives
ZA85853B (en) Antibacterial agents
ZA851949B (en) 1,2,4-triazacycloalkadiene derivatives
IL85451A (en) 26, 27-mono- and 14,15:26,27-diepoxy g22-ll-f28249 derivatives and their pesticidal use
IL71769A0 (en) 4,4'-alkylenedipiperidine derivatives
PH21777A (en) 3-mercapto-1,2,4-triazacycloalkadiene derivatives
GB2093024B (en) 2,4,8-triazaphenalenium salts and their preparation
GB8523735D0 (en) 1,2-benzoxathiine derivatives
GB2179350B (en) 7-oxo-4-thia-1-azabicyclo3.2.0hept-2-ene derivatives
IE841028L (en) 5,6-dihydropyran-2-one derivatives
IE841962L (en) 1,6 - naphtyridinone derivatives
IE841963L (en) 1,6 - naphthyridinone derivatives